Accelerating clinical trials during an epidemic

How should clinical trials be executed during a crisis such as an epidemic? Which aspects, if any, of the clinical trial process will change? Who needs to be involved and when do people need to act to ensure efficient management of the research? The National Academies...

Empowered Patients in Clinical Trials

Reading an article by Ed Miseta, Clinical Leader, brought to mind the importance of the balance of patient’s needs and scientific advancement.  Miseta’s article shared comments from leaders in Pharma where empowered patients and their community voice is recognized and...
Page 1 of 1712345...10...Last »